Pax World Management Llc Upped Catalent Inc (NYSE:CTLT) Position as Price Declined by $10.74 Million

May 16, 2018 - By Megan Stone

Catalent, Inc. (NYSE:CTLT) Corporate LogoBig Money Sentiment decreased to 1.44 in Q4 2017. It has change of 1.17, from 2017Q3’s 2.61. The ratio dropped due to CTLT positioning: 37 sold and 68 reduced. 41 funds took positions and 110 increased positions. Investors holded 130.89 million in 2017Q3 but now own 130.69 million shares or 0.15% less. Schroder Gp has invested 0.25% in Catalent, Inc. (NYSE:CTLT). Lpl Limited Liability Com reported 0% stake. First Quadrant L P Ca has 0.07% invested in Catalent, Inc. (NYSE:CTLT) for 90,251 shs. Massachusetts Fincl Svcs Ma reported 12,869 shs or 0% of all its holdings. Foundry Ltd Liability Com holds 0.06% of its capital in Catalent, Inc. (NYSE:CTLT) for 33,560 shs. Emerald Mutual Fund Advisers reported 568,178 shs. Ajo Limited Partnership invested in 0.15% or 859,675 shs. Segall Bryant And Hamill Limited Liability Corp reported 219,945 shs. Voya Management Ltd Co owns 0.09% invested in Catalent, Inc. (NYSE:CTLT) for 1.09 million shs. Delta Asset Limited Liability Company Tn accumulated 56 shs. Campbell & Comm Investment Adviser Ltd accumulated 5,029 shs. Prescott Group Capital Management Limited Liability Company holds 0.29% or 34,000 shs. Jennison Assocs Lc invested in 15,993 shs. Jane Street Gp Limited Company has 5,226 shs. First Tru L P reported 0.02% in Catalent, Inc. (NYSE:CTLT).

CTLT registered $7.57 million net activity with 0 insider purchases and 2 insider sales since December 11, 2017. $7.19M worth of Catalent, Inc. (NYSE:CTLT) was sold by Chiminski John R.

In Catalent Inc (NYSE:CTLT) was upped the holdings held by Pax World Management Llc. The increase is 152.29% according to 2018Q1 SEC regulatory filling. 261,851 shares were bought by Pax World Management Llc as Catalent Inc (NYSE:CTLT) stock declined 4.27% with the market. In 2018Q1, Pax World Management Llc held 433,796 shares of Catalent Inc (NYSE:CTLT), valued at $17.81 million, up from 171,945 last quarter. $5.25B is the Catalent Inc’s market cap. Ticker’s shares touched $39.38 during the last trading session after 0.33% change.Currently Catalent, Inc. is uptrending after 39.51% change in last May 16, 2017. CTLT has 506,354 shares volume. The stock outperformed the S&P500 by 27.96%.

Pax World Management Llc cut its stake in Ss&C Technologies Hldgs Inc (NASDAQ:SSNC) and reduced Apple Inc (NASDAQ:AAPL) position by 102,500 shares for a total of 142,375 shares.

Pax World Management Llc is a New Hampshire-based institutional investor with more than $3.21 billion AUM in July, 2014. Taken from Pax World Management latest Adv, the fund reported to have 46 full and part-time employees. Among which 15 performing investment advisory and research functions. The institutional investor had between 11-25 clients.

Catalent, Inc. (NYSE:CTLT) Ratings Coverage

A total of 8 analysts rate Catalent (NYSE:CTLT) as follows: 5 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 63% are bullish. (NYSE:CTLT) has 9 ratings reports on 16 May 2018 according to StockzIntelligence. The stock rating was upgraded by KeyBanc Capital Markets to “Overweight” on Wednesday, March 28. In Wednesday, March 21 report Raymond James upgraded the stock to “Outperform” rating. The company rating was maintained by Jefferies on Monday, February 5. The company rating was maintained by RBC Capital Markets on Monday, February 5. On Tuesday, February 6 the firm has “Buy” rating given by Bank of America. The stock rating was downgraded by Stephens to “Hold” on Tuesday, February 6.

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.The company has $5.25 billion market cap. It operates through three divisions: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services.71.86 is the P/E ratio. The Softgel Technologies segment offers formulation, development, and manufacturing services for softgels, which are used in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics.

Catalent, Inc. (NYSE:CTLT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: